Evidence map›Paper›PMID 32144714›Full record

Observational studyAdvances in therapy2020

Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM).

Fatheya F Al Awadi, Akram Echtay, Monira Al Arouj, Sobia Sabir Ali, Naim Shehadeh, Abdulrahman Al Shaikh, Khier Djaballah, Cecile Dessapt-Baradez, Mohamad Omar Abu-Hijleh, Abdullah Bennakhi and 4 more

Registry-linked trialOpen access · hybridAbstract readObservational Study
In one paragraph

Observational study in Advances in therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06416202 (Comparative Efficacy of Advanced Hybrid Closed Loop), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06416202 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Comparative Efficacy of Advanced Hybrid Closed Loop (AHCL) Therapy Versus Open-Loop Insulin Delivery (OLID) System in Type 1 Diabetes Management During Ramadan: A Randomized Controlled Trial

TypeinterventionalSponsorKing Fahad Medical CityRan2024 to 2025Enrolled75ConditionsInsulin Pump TherapyArmsAdvanced hybrid closed loop insulin pump, Open Loop Insulin Delivery system
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Type 1 diabetes mellitus in children: experience in Indonesia.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2021
    Review
  14. Ramadan and Diabetes: A Narrative Review and Practice Update.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Review
  15. Ramadan and Diabetes: A Narrative Review and Practice Update.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Review
  16. Patient Care During Ramadan: A Narrative Review.Health services research and managerial epidemiology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 12 countries.

Fatheya F Al AwadiDubai Hospital, Dubai, United Arab Emirates. ffAlawadi@dha.gov.ae.ORCID http://orcid.org/0000-0001-8911-866X
Akram EchtayRafic Hariri University Hospital, Beirut, Lebanon.
Monira Al AroujDasman Diabetes Institute, Kuwait City, Kuwait.
Sobia Sabir AliLady Reading Hospital, Peshawar, Pakistan.
Naim ShehadehRambam Medical Center, Haifa, Israel.
Abdulrahman Al ShaikhKing Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Khier DjaballahSanofi, Paris, France.
Cecile Dessapt-BaradezSanofi, Guildford, UK.
Mohamad Omar Abu-HijlehJordan Hospital, Amman, Jordan.
Abdullah BennakhiDasman Diabetes Institute, Kuwait City, Kuwait.
Mohamed El Hassan GharbiIbn Sina Hospital, Rabat, Morocco.
Khaled El Sayed El HadidyBeni Suef University, Beni Suef, Egypt.
Faris Abdul Kareem KhazaalAlkindy Obesity Center, Baghdad, Iraq.
Mohamed M HassaneinDubai Hospital, Dubai, United Arab Emirates.
Dasman Diabetes Institute · KWDubai Hospital · AEBaghdad Medical City · IQBeni-Suef University · EGCentre Hospitalier Ibn Sina · MAJordan Hospital · JOKing Abdulaziz University · SALady Reading Hospital · PKRafik Hariri University Hospital · LBRambam Health Care Campus · ILSanofi (France) · FRSanofi (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo describe the characteristics and care of participants with type 1 diabetes during Ramadan in the Middle East and North Africa.

methodsThe DAR-MENA (Diabetes and Ramadan-Middle East and North Africa) study was a prospective, observational study of adults with type 1 and type 2 diabetes who were Muslim and did/did not intend to fast during Ramadan 2016. Baseline data were collected 6 weeks prior to Ramadan, with a follow-up visit 1-2 months after Ramadan. This is the analysis of the population with type 1 diabetes. Measurements included proportion who fasted, reasons for fasting and not fasting, changes in diabetes treatment, hypoglycemic events, and proportion with access to diabetes education.

resultsOf 136 participants with type 1 diabetes, 76.9% (100/130) fasted for at least 1 day, 72.3% (94/130) fasted for at least 15 days, and 48.5% (63/130) fasted for 30 days. The majority (63.0%, 63/100) reported personal decision as a reason to fast. Fear of diabetic complications (58.6%, 17/29) and previous complications related to fasting (48.3%, 14/29) were the most common reasons for not fasting. Adjustment of diabetic medication regimen occurred for 84.6% (115/136) of participants, and 72.8% (99/136) changed their treatment dose. The incidence and number of adverse events for confirmed and severe hypoglycemia were similar before and during Ramadan. Almost half of participants had access to diabetes education (45.6%, 62/136).

conclusionThe DAR-MENA study showed that despite the risks associated with fasting for people with type 1 diabetes, almost half fasted for the full 30 days of Ramadan with no significant change in hypoglycemia events. Since the current International Diabetes Federation and Diabetes and Ramadan guidelines do not endorse fasting for people with type 1 diabetes, it is important that those who insist on fasting work closely with their healthcare practitioner to avoid any complications.

Indexed as

Adaptation, PhysiologicalAdultDiabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FastingFemaleHumansHyperglycemiaHypoglycemic AgentsIncidenceIslamMaleMiddle AgedPatient Education as TopicProspective StudiesHypoglycemic AgentsEpidemiologyFastingHypoglycemiaRamadanType 1 diabetes

Identifiers

PMID32144714
PMCPMC7140750
OpenAlexW3010486188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.